GENinCode Plc: FDA Pre-Submission Filed for Cardio inCode-SCORE
Commencement of regulatory pathway for U.S. market approvalOXFORD, England, Jan. 11, 2022Plc (AIM: GENI), the predictive genetics company focused on the prevention of cardiovascular disease, announces
Source: finanznachrichten.de